Almost half of pharmaceutical industry profits continue to come from biopharmaceuticals.
David Lin
Advertisement
David Lin, Ph. D., is with the Biologics Consulting Group.
Articles by David Lin
A two-day workshop on the "science behind pharmaceutical stability" was held in conjunction with the Annual Meeting of American Association of Pharmaceutical Scientists (AAPS) on Oct. 21-22, 2011 in Washington, DC.
Advertisement
Latest Updated Articles
Trends Affecting Biopharmaceutical ManufacturingOctober 2nd 2021
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
GSDIa Gene Therapy Approval Signals New Path for Rare Disease Manufacturing
2
Ask the Expert: Complying with Standards
3
How the Nitrosamine Guidance Shift is Changing LC-MS Workflows for APIs and Peptides
4
Q&A: Why Sponsors Are Turning to Mixed FSP/FSO Models
5